Frequently Asked Questions

Medication

Semaglutide 2.5 mg/1ml

The recommended starting dose is 0.25 mg (10 units) once weekly for 4 weeks, followed by an increase to 0.5 mg (20 units) once weekly.

After at least 4 weeks, the dose may be increased to 1 mg  once weekly if additional glycemic control or weight loss is needed.

Tirzepatide 10mg/ml

The recommended starting dose is 2.5 mg (25 units) once weekly for 4 weeks, followed by an increase to 10 mg (50 units) once weekly.

After at least 4 weeks, the dose may be increased to 7.5 mg once weekly if additional glycemic control or weight loss is needed.

Please note that this information is for reference only and should not replace the advice of a healthcare professional.

When injecting medication subcutaneously—that is, into the fatty tissue just beneath the skin—it's important to use the correct technique and to alternate the injection sites. Here’s a simple guide on how to do it:

1. Prepare Your Injection:

   • Wash your hands thoroughly with soap and water.

   • Make sure your medication is at room temperature.

   • Clean the vial’s rubber stopper with an alcohol swab if you're using a multi-dose vial.

   • Use a new, sterile needle and syringe for each injection.

2. Choose Your Injection Site:

   • Common sites for subcutaneous injections include the upper arms, thighs, buttocks, or abdomen.

   • Avoid areas where the skin is irritated, wounded, or has significant scar tissue.

3. Prepare the Site:

   • Clean the skin at the injection site with an alcohol swab and let it air dry.

   • Do not touch this area again before injecting.

4. Inject the Medication:

   • Pinch a 1-2 inch fold of skin between your fingers.

   • Hold the syringe like a pencil and insert the needle at about a 45-degree angle to the skin fold.

   • Once the needle is fully inserted, release the skin fold and inject the medication slowly and steadily.

   • Wait a few seconds, then withdraw the needle and gently press an alcohol swab over the site for a few seconds.

5. Rotate Your Injection Sites:

   • To help reduce skin irritation and increase the medication's efficacy, rotate the injection sites.

   • Use a different site each week and avoid using the same site more than once every month or two.

   • Keeping a log can help you track which sites you’ve used and when.

This method helps ensure that the medication is absorbed consistently and reduces the risk of tissue damage, making your treatment more effective.

Semaglutide

• Nausea: Often occurs early in treatment and may decrease over time.

• Diarrhea: Can occur along with other gastrointestinal symptoms.

• Vomiting: Similar to nausea, this may diminish as your body adjusts to the medication.

• Constipation: May occur, sometimes alleviated with dietary adjustments.

• Abdominal pain: Discomfort in the stomach area is common.

• Headaches: Some people experience headaches, especially when starting treatment.

​

Tirzepatide

• Nausea and vomiting: These are common as the body adjusts to the medication.

• Diarrhea: Frequently reported, especially in the initial phases of treatment.

• Reduced appetite: Many users notice a decrease in hunger.

• Constipation: A common side effect that may require dietary changes to manage.

• Abdominal pain: General discomfort in the abdominal area.

• Injection site reactions: Redness, irritation, or pain around the area where the shot was given.

Both medications can impact digestion as your body adapts to them. If you experience any severe or persistent side effects, it’s important to contact your healthcare provider.